InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,264.17
(
0.27%
)

Replies to post #4139 on Amarin Corp Plc (AMRN)

Replies to #4139 on Amarin Corp Plc (AMRN)

DewDiligence

04/12/13 3:57 PM

#4180 RE: Biobillionair #4139

The Abilify patent you cited (5,006,528) is a composition-of-matter patent on a novel drug. Those kinds of patents are the hardest for generic-drug companies to invalidate.